DOW
52
2
FTI
64
-2
AIV
48
-2
HPE
69
-2
LUV
81
4
TDC
46
-3
AMT
49
3
DD
64
3
HBI
62
-2
BWA
67
12
RIG
14
-5
ETN
69
2
AMZN
57
2
ILMN
45
-4
MNST
46
-3
EQR
45
-2
ADP
72
2
CA
18
-9
MSI
58
3
CL
53
-3
DOW
52
2
FTI
64
-2
AIV
48
-2
HPE
69
-2
LUV
81
4
TDC
46
-3
AMT
49
3
DD
64
3
HBI
62
-2
BWA
67
12
RIG
14
-5
ETN
69
2
AMZN
57
2
ILMN
45
-4
MNST
46
-3
EQR
45
-2
ADP
72
2
CA
18
-9
MSI
58
3
CL
53
-3
Financhill
Back

Apellis Pharmaceuticals Vs. Avidity Biosciences Industry Stock Comparison

Sell
37

APLS
Apellis Pharmaceuticals

Last Price:
$19.54
Seasonality Move:
-16.64%
Sell
47

RNA
Avidity Biosciences

Last Price:
$31.46
Seasonality Move:
-6.84%
Sell
37
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $19.21. The Score for APLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $31.27. The Score for RNA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $19.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $31.27
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 57.88 Buy
Chaikin Money Flow: 3142813 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.69 - 19.09) Buy
Bollinger Bands (100): (17.14 - 24.36) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.3 Buy
Relative Strength Index (14 RSI): 55.96 Buy
Chaikin Money Flow: 3472213 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.61 - 33.19) Buy
Bollinger Bands (100): (27.86 - 32.62) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.9 Buy
20-day SMA: 18.23 Buy
50-day SMA: 18.18 Buy
200-day SMA: 25.58 Sell
8-day EMA: 18.16 Buy
20-day EMA: 18.15 Buy
50-day EMA: 18.77 Buy
200-day EMA: 25.96 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.22 Buy
20-day SMA: 29.97 Buy
50-day SMA: 30.65 Buy
200-day SMA: 34.71 Sell
8-day EMA: 12 Buy
20-day EMA: 5.5 Buy
50-day EMA: 2.33 Buy
200-day EMA: 0.6 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.23 per share, and an increase next year of $0.73 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.15 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.46 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):